IQVIA Holdings Inc. Q3 2025 Earnings Recap

IQV Q3 2025 October 28, 2025

Get alerts when IQV reports next quarter

IQVIA reported solid third-quarter 2025 results, with revenues and profits at the high end of guidance, driven by robust operational performance and impressive free cash flow.

Earnings Per Share Beat

$3.00 vs $2.98 est.

+0.7% surprise

Revenue Beat

4100000000 vs 4079623150 est.

+0.5% surprise

Market Reaction

1-Day +0.32%

5-Day -0.45%

30-Day -0.15%

See IQV alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue growth of 5.2% year-over-year, with adjusted diluted EPS rising 5.6%.
Record backlog of $32.4 billion, up 4.1% compared to the prior year, reflecting strong demand trends.
Net bookings reached $2.6 billion, translating to a favorable net book-to-bill ratio of 1.15x, driven by improved customer demand.
Continued strength in the TAS segment with successful drug launches contributing to overall results.
Strong free cash flow this quarter marks the highest ever, highlighting effective working capital management.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit IQV on AllInvestView.

Next Q1 2026